2016 annual financial data
Rigel Pharmaceuticals 2016 Operating margin
Direct answer
Operating margin was -342.15%.
Operating income was -69,741,000 USD and net income was -69,216,000 USD.
Operating cash flow was -75,889,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,383,000 USD
- Operating income
- -69,741,000 USD
- Net income
- -69,216,000 USD
- Operating cash flow
- -75,889,000 USD